Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Schedule of company’s share capital

	December 31, 2021				December 31, 2020
	Authorized		Issued and outstanding		Issued and outstanding		Issued and outstanding
	Number of shares
Shares of common stock of $0.0001 par value each “Shares”		500,000,000		4,194,385		500,000,000		3,167,560

Schedule of warrant activity

	Number			Average exercise price
Warrants outstanding at January 1, 2020		115,083		$	16.90
Granted		108,000			1.80
Exercised		-			-
Forfeited/Cancelled		(10,000	)		20
Warrants outstanding at December 31, 2020		213,083		$	8.10
Granted		99,000			1.50
Exercised		-			-
Forfeited/Cancelled		(66,000	)		1.50
Forfeited/Cancelled		(47,333	)		19.40
Warrants outstanding at December 31, 2021		198,750		$	5.40

Schedule of option outstanding activity

Issuance date	Warrants outstanding		Exercise price per warrant		Warrants outstanding and exercisable		Expiry date
February 21, 2019		13,750	$	20.00		13,750	February 21, 2022
October 15, 2019		44,000	$	12.50		44,000	October 15, 2024
August 7, 2020		50,000	$	2.00		50,000	August 7, 2025
August 11, 2020		25,000	$	2.00		25,000	August 11, 2025
December 31, 2021		66,000	$	1.50		66,000	December 31, 2022
		198,750				198,750

Schedule of employee share options activity

	Number			Average weighted exercise price
Options outstanding at January 1, 2020		160,588			10.00
Granted		166,000			1.10
Exercised		-			-
Forfeited		(160,588	)		-
Options outstanding at December 31, 2020		166,000			1.10
Granted		120,000			0.01
Exercised		(90,000	)		1.10
Forfeited		(1,000	)		3.00
Options outstanding at December 31, 2021		195,000		$	0.63
Options exercisable at December 31, 2021		131,250		$	0.70

Schedule of option outstanding activity

Issuance date	Options outstanding		Exercise price per option		Options outstanding and exercisable		Expiry date
September 1, 2020		15,000	$	0.70		6,250	September 1, 2025
October 13, 2020		50,000	$	1.00		25,000	October 12, 2023
November 3, 2020		25,000	$	1.00		25,000	October 25, 2025
November 3, 2020		25,000	$	1.50		25,000	October 25, 2025
December 14, 2021		80,000	$	0.01		50,000	December 14, 2026
		195,000				131,250

Schedule of RSU activity

	Number
RSU outstanding at January 1, 2020		13,025
Granted (i) (ii)		103,500
Exercised		(67,500	)
Forfeited		-
RSU’s outstanding at December 31, 2020		49,025
Granted (iii) (iv) (v)		227,500
Exercised (Note 6b (2)(3)(8))		(80,525	)
Forfeited		-
RSU’s exercisable at December 31, 2021		196,000

(i)	On September 1, 2020, the Company, the Company granted the CFO 36,000 RSU’s with an exercise price of nil. The RSU’s vest quarterly over three years. The fair value of the RSU’s at the date of the grant was $30. During the years ended December 31, 2021 and 2020, the Company recorded share-based expenses related to the RSU’s in the amount of $10 and $3, respectively
(ii)	On November 24, 2020, The Company granted two directors 30,000 RSU’s each, and one director 7,500 RSU’s. All these RSU’s vest immediately and have an exercise price of nil. The fair value of the RSU’s at the date of the grant was $128.
(iii)	During the period between February 2021 through to March 2021, the Company granted two directors 30,000 RSU’s each. The fair value of the RSU’s at the date of the grant was $334.
(iv)	On October 5, 2021, the Company granted a director 7,500 RSU’s. The fair value of the shares at the date of the grant was $18.
(v)	On December 14, 2021, the Company granted five directors 144,000 RSU’s. The fair value of the shares at the date of the grant was $111. The RSU’s vest quarterly in advance over one year.